Tag: VentureMed Group
VentureMed to present new data on DCB treatment for PAD
VentureMed Group has announced new data presentations on the treatment of peripheral arterial disease (PAD) with drug-coated balloon (DCBs) in addition to 12-month AV...
VentureMed completes enrolment of Flex Vessel Prep system randomised controlled trial...
VentureMed Group recently announced that it has completed enrolment of a randomised controlled trial (RCT) titled 'Flex Vessel Prep prior to PTA for the...
LINC 2021: Three studies evaluating Flex Vessel Prep system presented
VentureMed Group announced today that data from three studies evaluating the use of its Flex Vessel Prep (VP) system were presented during LINC 2021...
Flex Vessel Prep system receives new indication to address in-stent restenosis
VentureMed Group recently announced that the US Food and Drug Administration (FDA) cleared the company's Flex Vessel Prep system for use in the treatment...
BELONG study enrols first patients
Enrolment of the first patients in the BELONG study—benefit of arterial vessel preparation by arterial by longitudinal micro-incisions before drug-eluting balloon angioplasty of the...
Second iDissection Classification study to evaluate dissection rate of FLEX Dynamic...
VentureMed Group has announced the initiation of a new study to determine if the FLEX Dynamic Scoring Catheter reduces dissections and the need for...
